Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation : a potentially catastrophic problem in a vulnerable population
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-01-15
著者
-
KHARFAN-DABAJA Mohamed
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
-
VELEZ Ana
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
-
RICHARDS Karla
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
-
GREENE John
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
-
FIELD Teresa
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
-
SANDIN Ramon
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
-
Greene John
Department Of Blood And Marrow Transplantation H. Lee Moffitt Cancer Center And Research Institute
-
Velez Ana
Department Of Blood And Marrow Transplantation H. Lee Moffitt Cancer Center And Research Institute
-
Richards Karla
Department Of Blood And Marrow Transplantation H. Lee Moffitt Cancer Center And Research Institute
-
Sandin Ramon
Department Of Blood And Marrow Transplantation H. Lee Moffitt Cancer Center And Research Institute
-
Field Teresa
Department Of Blood And Marrow Transplantation H. Lee Moffitt Cancer Center And Research Institute
-
Kharfan-dabaja Mohamed
Department Of Blood And Marrow Transplantation H. Lee Moffitt Cancer Center And Research Institute
関連論文
- Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation : a potentially catastrophic problem in a vulnerable population
- Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications